Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.


Universal Ibogaine Inc. (V:IBO)

Business Focus: N/A

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

Insider Filings

Latest 10 SEDI filings for IBO within the last 6 months
See all filings within the past 6 months

Company News

Oct 05, 2022 06:30 ET
Universal Ibogaine Announces Results of Annual General Meeting
Calgary, AB – TheNewswire - October 5, 2022 – Universal Ibogaine Inc. (TSXV:IBO) (“UI” or the “Company”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, is pleased to announce that all resolutions were passed by the requisite majority of shareholders at its annual general meeting (“AGM”) which was held on October 3, 2022 in Vancouver, BC.  
Read full article
Oct 03, 2022 14:37 ET
Universal Ibogaine Undertaking Offering of Convertible Debt Securities and Common Shares
Calgary, AB – TheNewswire - October 3, 2022 – Universal Ibogaine Inc. (TSXV:IBO) (“UI” or the “Company”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises that it is in process of finalizing an offering (the “Offering”) of convertible debt securities.  The Offering will consist of “Secured Guarantee Convertible Notes” (the “Notes”) which will bear interest at 8% (payable quarterly) and have a maturity of 3 years from the Closing of the Offering.  Closing of the Offering, and the payment of any finders fees related thereto, is subject to t
Read full article
See more news stories

Valuation Ratios

Price to Sales - TTM
Price to Book - most recent quarter
Price to Cash Flow per share - TTM
Price to Free Cash Flow per share - TTM
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Sep 15, 202200
Aug 31, 202200
Aug 15, 202200
See Short Report

Business Summary

Sector:  N/A Industry:  N/A

See business summary



Search (past week) for $IBO.CA IBO.V